Author:
Chang Jee Suk,Kim Sang Wun,Kim Yeon-Joo,Kim Joo-Young,Park Sang-Yoon,Kim Jin Hee,Jang Tae-Kyu,Kim Yong Bae
Subject
Obstetrics and Gynaecology,Oncology
Reference24 articles.
1. Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study;Pignata;J. Clin. Oncol.,2017
2. NCCN Clinical Practice Guidelines in Oncology, Ovarian Cancer, Version 5;Fort Washington,2017
3. Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer;Aghajanian;Gynecol. Oncol.,2015
4. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients;Wagner;Br. J. Cancer,2012
5. Role of radiation therapy;Eifel;Best Pract. Res. Clin. Obstet. Gynaecol.,2017
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献